A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Emerging as the leader in ultra-rare diseases treatments, Alexion has been a huge success story, bringing breakthroughs to disabling and fatal conditions. But this success brings pressure from ...

Several pharma companies lose out in a ruling that prevents them making generic oxycodone over fears of misuse. In a controversial decision that hands a victory to Purdue Pharma, the US Food and ...